Fluoxetine for Maintenance of Remission and to Improve Quality of Life in Patients with Crohn’s Disease: a Pilot Randomized Placebo-Controlled Trial

BACKGROUND AND AIMS: Previous studies have shown that antidepressants reduce inflammation in animal models of colitis. The present trial aimed to examine whether fluoxetine added to standard therapy for Crohn’s disease [CD] maintained remission, improved quality of life [QoL] and/or mental health in...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikocka-Walus, Antonina, Hughes, Patrick A., Bampton, Peter, Gordon, Andrea, Campaniello, Melissa A., Mavrangelos, Chris, Stewart, Benjamin J., Esterman, Adrian, Andrews, Jane M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881791/
https://www.ncbi.nlm.nih.gov/pubmed/27664274
http://dx.doi.org/10.1093/ecco-jcc/jjw165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881791/
https://www.ncbi.nlm.nih.gov/pubmed/27664274
http://dx.doi.org/10.1093/ecco-jcc/jjw165

Ejemplares similares